Water

Main information

  • Trade name:
  • Water for Injection 100% v/v Solvent For Parenteral Use (Animalcare)
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Water for Injection 100% v/v Solvent For Parenteral Use (Animalcare)
    United Kingdom
  • Language:
  • English

Other information

Status

  • Source:
  • VMD - Veterinary Medicines Directorate
  • Authorization status:
  • Expired
  • Authorization number:
  • 41687/4003
  • Last update:
  • 21-12-2016

Summary of Product characteristics

Revised: October 2012

AN: 00749/2012

SUMMARY OF PRODUCT CHARACTERISTICS

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Water for Injection 100% v/v. Solvent For Parenteral Use (Animalcare)

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active Substance:

Water for Injection 100 %v/v

Excipients:

For a full list of excipients, see section 6.1

3. PHARMACEUTICAL FORM

Solvent for parenteral use.

A clear solution for injection.

4. CLINICAL PARTICULARS

4.1 Target species

As required.

4.2 Indications for use, specifying the target species

For use as a sterile solvent for the preparation of medicines intended

for   parenteral   administration   where   water   is   a   component   of   the

preparation and for reconstituting or diluting medicines for parenteral

administration immediately before use.

4.3 Contraindications

None

4.4 Special Warnings for each target species

No special warnings

4.5 Special precautions for use

Special precautions for use in animals

None

Page 1 of 3

Revised: October 2012

AN: 00749/2012

ii. Special precautions to be taken by the person administering the

veterinary medicinal product to animals

None

4.6 Adverse reactions (frequency and seriousness)

None

4.7 Use during pregnancy, lactation or lay

Water for Injection (Animalcare) is safe for use during pregnancy and

lactation.

4.8 Interaction   with   other   medicinal   products   and   other   forms   of

interaction

None

4.9 Amounts to be administered and administration route

For parenteral use.

Dosage: as required

4.10 Overdose   (symptoms,   emergency   procedures,   antidotes),   if

necessary

Not applicable

4.11 Withdrawal period

Meat: Zero days

Milk: Zero hours

5. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group:  Solvent and diluting agents

ATC Vet Code:  QV07AB

5.1 Pharmacodynamic properties

Water   for   Injections   is   sterile   distilled   water   intended   for   use   as   an

injectable solvent and has no pharmacological actions.

6. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

None 

Page 2 of 3

Revised: October 2012

AN: 00749/2012

6.2 Incompatibilities

None Known.

6.3 Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 2

years

6.4 Special precautions for storage

Do not store above 25 C

Take adequate precautions to maintain sterility.

Any solution remaining in the vial following withdrawal of the required

dose should be discarded.

6.5 Nature and composition of immediate packaging

Water for Injection (Animalcare) is packaged in 20ml, 50ml and 100ml

clear grade I glass vials with bromobutyl bungs and aluminium seals.

Not all pack sizes may be marketed

6.6 Special precautions for the disposal of unused veterinary medicinal

product or waste materials derived from the use of such products

Any unused veterinary medicinal product or waste materials derived

from   such   veterinary   medicinal   products   should   be   disposed   of   in

accordance with local requirements.

7. MARKETING AUTHORISATION HOLDER

Listow Limited

9 Belgrave Square

London

SW1X 8PH

8. MARKETING AUTHORISATION NUMBER(S)

Vm:

 41687/4003

9. DATE OF FIRST AUTHORISATION

Date: 14 May 2002 

10. DATE OF REVISION OF THE TEXT

Date: October 2012

Page 3 of 3

1-6-2018

Demulen 30 birth control pills: Packages containing broken or chipped pills

Demulen 30 birth control pills: Packages containing broken or chipped pills

Pfizer Canada Inc. has notified Health Canada that it has received complaints of broken or chipped pills involving Demulen 30, a prescription birth control pill. Health Canada has previously communicated on similar issues involving two other brands of birth control pills. Health Canada continues to remind women to check their packages of birth control pills and to report problems if they see them. If you notice anything unusual in the package, such as missing or damaged pills, you should return the packa...

Health Canada

1-5-2018

Do You Vape? See These Tips on How to Keep E-Liquids Away from Children

Do You Vape? See These Tips on How to Keep E-Liquids Away from Children

Accidentally touching or drinking e-liquids can be dangerous and even deadly for young children. So it’s important to handle and store these products carefully, to teach children to stay away from these products, and to be prepared for emergencies. Consider these tips.

FDA - U.S. Food and Drug Administration

8-5-2015

Annual Pharmacovigilance Report 2014

Annual Pharmacovigilance Report 2014

In our annual pharmacovigilance report 2014, you can read about the development in the number of ADR reports, learn about various focus areas and the European collaboration in the pharmacovigilance area as well as see a selection of the ADR signals we processed in 2014, and much more.

Danish Medicines Agency

25-5-2018

CDC wants to see your #SunSafeSelfie! Photograph yourself with protections such as sunglasses, a hat, long-sleeves & sunscreen and share your pic on social media:  https://goo.gl/jr1nP7 pic.twitter.com/hKJbKLnwni

CDC wants to see your #SunSafeSelfie! Photograph yourself with protections such as sunglasses, a hat, long-sleeves & sunscreen and share your pic on social media: https://goo.gl/jr1nP7 pic.twitter.com/hKJbKLnwni

CDC wants to see your #SunSafeSelfie! Photograph yourself with protections such as sunglasses, a hat, long-sleeves & sunscreen and share your pic on social media: https://goo.gl/jr1nP7  pic.twitter.com/hKJbKLnwni

FDA - U.S. Food and Drug Administration

30-4-2018

Regulatory and procedural guideline:  Draft guideline on the summary of product characteristics (SPC) for veterinary medicinal products containing antimicrobial substances, draft: consultation open

Regulatory and procedural guideline: Draft guideline on the summary of product characteristics (SPC) for veterinary medicinal products containing antimicrobial substances, draft: consultation open

The guideline, which was developed to encourage optimal use and to minimise selection of antimicrobial resistance (AMR), was revised in order to improve consistency of the summary of product characteristics (SPCs) for antimicrobial products in the EU Member States.

Europe - EMA - European Medicines Agency